Zenman Icon

Where are you viewing this site?

Map of Contents United States International

Bio2 Medical® Announces 510(k) Clearance from the FDA for the Angel® Catheter, the First Ever Prophylactic Use Indication for a Medical Device ...

Visit Original Article

Bio2 Medical Enrolls Subjects in the New U.S. FDA Early Feasibility Pilot Study for the Angel® Catheter

Visit Original Article

Bio2 Medical Executes Q4 2013 Commercialization Strategy for the Angel® Catheter, Signing Distribution Partnership Agreements in Key European ...

Visit Original Article

Bio2 Medical Executes Full Commercialization in the United Kingdom Partnering with United Drug Medical (UDM) as an Exclusive Distributor for the ...

Visit Original Article

UK Hospital is the first in Europe to place Bio2 Medical’s combined triple lumen CVC/IVC Filter, known as the Angel® Catheter, in a critically ...

Visit Original Article

Bio2 Medical’s combined triple lumen/IVC Filter marketed as the Angel® Catheter receives CE Mark, and will be introduced at the United Kingdom ...

Visit Original Article

Bio2 Medical Granted CE Mark for the Angel® Catheter, the First IVC Filter with a Prophylactic Use Indication

Visit Original Article